Back to search

Article

LRP1B affects lung adenocarcinoma immunotherapy efficacy via ferroptosis

2023-07-11

Abstract excerpt

<title>Abstract</title><p>Background Currently, the clinically used immune biomarkers for non-small cell lung cancer (NSCLC) are programmed death ligand 1 (PD-L1) and tumor mutation burden (TMB). However, they cannot accurately predict the effectiveness of immunotherapy. Identifying appropriate biomarkers that can differentiate between beneficiary groups is imperative. Methods We identified LRP1B as a potential bi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e595367d-0512-57b8-9f04-e9adca2cc895
DOI
10.21203/rs.3.rs-3053993/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
LRP1B affects lung adenocarcinoma immunotherapy efficacy via ferroptosisDOI 10.21203/rs.3.rs-3053993/v1
Select a neighboring publication to make it the new centre.